R1	Has_temporal Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
R3	Has_value Arg1:T5 Arg2:T6	
R4	Subsumes Arg1:T4 Arg2:T5	
*	OR T8 T11 T9 T10
R5	Has_value Arg1:T7 Arg2:T8	
R6	Has_context Arg1:T14 Arg2:T13	
*	OR T16 T18 T17
R7	AND Arg1:T15 Arg2:T16	
*	OR T20 T21
R8	Has_value Arg1:T25 Arg2:T26	
R9	Has_context Arg1:T29 Arg2:T28	
R10	Has_qualifier Arg1:T29 Arg2:T27	
R11	AND Arg1:T24 Arg2:T25	
R12	Has_qualifier Arg1:T22 Arg2:T23	
*	OR T22 T24 T29
R13	Subsumes Arg1:T20 Arg2:T22	
*	OR T33 T34
R14	AND Arg1:T32 Arg2:T33	
R15	Has_temporal Arg1:T36 Arg2:T37	
*	OR T38 T39
*	OR T41 T42
R16	AND Arg1:T38 Arg2:T41	
R17	Has_temporal Arg1:T44 Arg2:T45	
*	OR T46 T47
*	OR T49 T50
R18	Subsumes Arg1:T46 Arg2:T49	
*	OR T46 T52 T53
*	OR T54 T55
*	OR T56 T58 T57
R19	AND Arg1:T54 Arg2:T56	
R20	Subsumes Arg1:T44 Arg2:T46	
R21	Subsumes Arg1:T63 Arg2:T62	
*	OR T65 T66
*	OR T67 T68
R22	Subsumes Arg1:T65 Arg2:T67	
*	OR T63 T64
R23	Has_temporal Arg1:T65 Arg2:T63	
R24	Subsumes Arg1:T44 Arg2:T54	
T1	Drug 23 37	bisphosphonate
T2	Temporal 0 5	Prior
T3	Measurement 48 62	renal function
T4	Value 39 47	Abnormal
T5	Measurement 81 112	calculated creatinine clearance
T6	Value 113 127	< 30 ml/minute
T7	Measurement 130 139;169 196	Corrected serum calcium concentration
T8	Value 197 208	< 8.0 mg/dl
T9	Value 210 221	2.00 mmol/L
T10	Value 226 238	â‰¥ 12.0 mg/dl
T11	Value 240 251	3.00 mmol/L
T13	Observation 269 291	clinically symptomatic
T14	Condition 292 308	brain metastases
T15	Temporal 310 317	History
T16	Condition 321 363	diseases with influence on bone metabolism
T17	Condition 372 387	Paget's disease
T18	Condition 392 419	primary hyperparathyroidism
T20	Condition 428 436;466 474	physical diseases
T21	Condition 440 453;466 474	psychological diseases
T22	Condition 637 644	ascites
T23	Qualifier 614 636	clinically significant
T24	Condition 646 661	cardiac failure
T25	Measurement 663 667	NYHA
T26	Value 668 677	III or IV
T27	Qualifier 679 698	clinically relevant
T28	Observation 699 718	pathologic findings
T29	Procedure 722 725	ECG
T32	Condition 733 749	hypersensitivity
T33	Drug 753 768	zoledronic acid
T34	Drug 772 793	other bisphosphonates
T36	Drug 802 829	other investigational drugs
T37	Temporal 830 872	30 days prior to the date of randomization
T38	Temporal 880 887	history
T39	Temporal 891 898	present
T41	Condition 899 915	abuse of alcohol
T42	Condition 899 907;919 924	abuse of drugs
T44	Condition 1041 1056	dental problems
T45	Temporal 1026 1033	Current
T46	Condition 1067 1089	infection of the teeth
T47	Condition 1067 1083;1093 1100	infection of the jawbone
T49	Condition 1067 1083;1102 1109	infection of the maxilla
T50	Condition 1067 1083;1113 1123	infection of the mandibular
T52	Condition 1126 1132;1144 1150	dental trauma
T53	Condition 1136 1150	fixture trauma
T54	Temporal 1157 1164	current
T55	Temporal 1168 1173	prior
T56	Condition 1187 1217	osteonecrosis of the jaw (ONJ)
T57	Condition 1222 1247	exposed bone in the mouth
T58	Condition 1255 1291	slow healing after dental procedures
T62	Temporal 1302 1316	within 6 weeks
T63	Temporal 1294 1300	Recent
T64	Mood 1321 1328	planned
T65	Procedure 1329 1335;1343 1350	dental surgery
T66	Procedure 1339 1350	jaw surgery
T67	Procedure 1357 1367	extraction
T68	Procedure 1369 1377	implants
T72	Non-query-able 926 1024	Subjects who, in the opinion of the investigator, are unlikely to cooperate fully during the study
T73	Non-representable 1380 1442	Other protocol defined inclusion/exclusion criteria may apply.
